NCT02824822View on ClinicalTrials.gov

Genetic Markers of Cardiovascular Disease in Epilepsy

RecruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2031

Study Completion Date

December 31, 2031

Conditions

EpilepsySeizuresSyncopeChannelopathyCardiomyopathies

Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

American Heart Association

OTHER

lead

Mayo Clinic

OTHER

NCT02824822 - Genetic Markers of Cardiovascular Disease in Epilepsy | Biotech Hunter | Biotech Hunter